Reductase inhibitor therapy of hypercholesterolemia.
作者信息
Kreisberg R A
机构信息
Department of Medicine, University of Alabama, Birmingham.
出版信息
Trans Am Clin Climatol Assoc. 1991;102:153-63; discussion 163-5.
Abstract
摘要
相似文献
1
Reductase inhibitor therapy of hypercholesterolemia.高胆固醇血症的还原酶抑制剂疗法。
Trans Am Clin Climatol Assoc. 1991;102:153-63; discussion 163-5.
2
Worldwide experience with simvastatin/lovastatin.
Eur Heart J. 1992 Jul;13 Suppl B:21-2. doi: 10.1093/eurheartj/13.suppl_b.21.
3
Statin therapy in clinical practice: new developments.临床实践中的他汀类药物治疗：新进展
Curr Opin Lipidol. 1995 Oct;6(5):254-5.
4
[Simvastatin in the treatment of hypercholesterolemia].[辛伐他汀治疗高胆固醇血症]
Clin Ter. 1991 Jun 15;137(5):333-7.
5
6
[Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].[瑞士辛伐他汀多中心研究：1. 每日10毫克辛伐他汀对原发性高胆固醇血症患者的疗效]
Schweiz Med Wochenschr. 1989 Dec 2;119(48):1719-23.
7
Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
N Z Med J. 1990 Feb 14;103(883):41-3.
8
[Rhabdomyolysis in patients treated with simvastatin and cyclosporin: role of the hepatic cytochrome P450 enzyme system activity].
Schweiz Med Wochenschr. 1995 Jul 11;125(27-28):1342-6.
9
HMGCoA reductase inhibitors lovastatin and simvastatin in the treatment of hypercholesterolemia after renal transplantation.HMGCoA还原酶抑制剂洛伐他汀和辛伐他汀在肾移植术后高胆固醇血症治疗中的应用。
Transplant Proc. 1993 Feb;25(1 Pt 2):1043-6.
10
Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis.辛伐他汀治疗原发性胆汁性肝硬化患者的胆汁淤积和高胆固醇血症效果显著。
Am J Gastroenterol. 1995 Jul;90(7):1187-8.
引用本文的文献
1
Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers.他汀类药物与蒽环类药物所致心脏毒性：Rac和Rho，以及“心碎者”
Cell Death Dis. 2017 Jan 19;8(1):e2564. doi: 10.1038/cddis.2016.418.
本文引用的文献
1
Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.采用联合用药方案使杂合子家族性高胆固醇血症患者的低密度脂蛋白水平正常化。
N Engl J Med. 1981 Jan 29;304(5):251-8. doi: 10.1056/NEJM198101293040502.
2
Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia.氯贝丁酯治疗肾病综合征高脂血症期间的并发症。
Lancet. 1972 Sep 9;2(7776):506-9. doi: 10.1016/s0140-6736(72)91905-8.
3
Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.
Ann Intern Med. 1987 Nov;107(5):616-23. doi: 10.7326/0003-4819-107-5-616.
4
Cholesterol and mortality. 30 years of follow-up from the Framingham study.胆固醇与死亡率。来自弗雷明汉心脏研究的30年随访
JAMA. 1987 Apr 24;257(16):2176-80. doi: 10.1001/jama.257.16.2176.
5
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.赫尔辛基心脏研究：吉非贝齐用于中年血脂异常男性的一级预防试验。治疗安全性、危险因素变化及冠心病发病率
N Engl J Med. 1987 Nov 12;317(20):1237-45. doi: 10.1056/NEJM198711123172001.
6
7
Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin.用洛伐他汀（美维诺林）或新霉素治疗的II型高脂蛋白血症患者的睾丸功能。
J Clin Endocrinol Metab. 1987 Sep;65(3):546-50. doi: 10.1210/jcem-65-3-546.
8
The effect of mevinolin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway.
J Clin Endocrinol Metab. 1987 Mar;64(3):531-5. doi: 10.1210/jcem-64-3-531.
9
Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
Circulation. 1989 Mar;79(3):590-6. doi: 10.1161/01.cir.79.3.590.
10
Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.辛伐他汀和消胆胺对家族性和非家族性高胆固醇血症的影响。多中心研究组I
Arch Intern Med. 1990 Feb;150(2):341-5.
Zotero 插件